Mesoblast Limited
MESO
$16.14
-$0.25-1.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.50M | -75.94M | -94.37M | -98.26M | -102.14M |
| Total Depreciation and Amortization | 8.59M | 8.61M | 8.63M | 7.51M | 6.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.90M | 37.74M | 46.58M | 47.70M | 48.83M |
| Change in Net Operating Assets | -23.82M | -22.15M | -20.48M | -11.76M | -3.04M |
| Cash from Operations | -43.83M | -51.74M | -59.64M | -54.80M | -49.95M |
| Capital Expenditure | -833.00K | -914.50K | -996.00K | -838.00K | -680.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -190.00K | -154.00K | -118.00K | 341.00K | 800.00K |
| Cash from Investing | -1.02M | -1.07M | -1.11M | -497.00K | 120.00K |
| Total Debt Issued | 121.35M | 96.35M | 71.35M | 35.68M | -- |
| Total Debt Repaid | -127.29M | -101.98M | -76.66M | -43.21M | -9.77M |
| Issuance of Common Stock | 10.28M | 90.44M | 170.59M | 168.49M | 166.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.68M | -17.24M | -14.81M | -12.05M | -9.28M |
| Cash from Financing | -15.33M | 67.57M | 150.47M | 148.90M | 147.34M |
| Foreign Exchange rate Adjustments | 1.55M | 1.89M | 2.23M | 1.66M | 1.09M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.64M | 16.65M | 91.95M | 95.27M | 98.59M |